Q1 2025 Earnings Call Transcript September 16, 2024 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported ...
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago. These ...
3d
ImmunoPrecise Antibodies (IPA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic ...
ImmunoPrecise Antibodies will report earnings from Q1.Analysts on Wall Street expect ImmunoPrecise Antibodies will release ...
Phreesia (PHR) delivered earnings and revenue surprises of 16.22% and 0.35%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies First Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in our company.
3d
Despite a year-over-year revenue decline, IPA shows promising growth in key labs and strategic advancements in AI-driven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback